1. Wu, Chao, Zhang, Jiajin, Wang, Kuan, Fan, Mengjiao, Hu, Yi. 2022. FAM117A Is a New Prognostic Marker of Lung Adenocarcinoma and Predicts Sensitivity to PD0332991. In Evidence-based complementary and alternative medicine : eCAM, 2022, 3945446. doi:10.1155/2022/3945446. https://pubmed.ncbi.nlm.nih.gov/35280504/
2. Peinado-Serrano, Javier, Quintanal-Villalonga, Álvaro, Muñoz-Galvan, Sandra, Ortiz-Gordillo, María J, Carnero, Amancio. 2022. A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer. In Cancers, 14, . doi:10.3390/cancers14092054. https://pubmed.ncbi.nlm.nih.gov/35565183/
3. Tu, Kun, Zhou, Wenhui, Kong, Shubing. 2024. Exploring biomarkers of Alzheimer's disease based on multi-omics and Mendelian randomisation analysis. In Annals of human biology, 51, 2415035. doi:10.1080/03014460.2024.2415035. https://pubmed.ncbi.nlm.nih.gov/39508514/
4. Bai, Maoshu, Liu, Xin, Wang, Lingling. 2023. Identification of potential tumor antigens and immune subtypes for lung adenocarcinoma. In Medical oncology (Northwood, London, England), 40, 100. doi:10.1007/s12032-023-01973-3. https://pubmed.ncbi.nlm.nih.gov/36809467/
5. Drouilhet, L, Lecerf, F, Bodin, L, Fabre, S, Mulsant, P. 2009. Fine mapping of the FecL locus influencing prolificacy in Lacaune sheep. In Animal genetics, 40, 804-12. doi:10.1111/j.1365-2052.2009.01919.x. https://pubmed.ncbi.nlm.nih.gov/19466934/
智鼠故事 
